Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
LYNX PHARMA AS
AS
Active
Org 931174673
Brevikveien 48, 3135
Torød
Other human health activities n.e.c.
·
NACE 8699
Est. 2023 · 3 years old
0 employees
Overvåg
Share
Norway
/
Companies
/
Other human health activities n.e.c.
/
LYNX PHARMA AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
EBITDA
NOK millions
0M
-0M
-1M
-1M
-1M
-1M
2023
0M
+100%
2024
Income statement
NOK thousands
Item
2023
2024
Revenue
0
0
Staff expenses
−0
−0
EBITDA
−547
−51
Depreciation & amort.
−0
−0
EBIT
−547
−51
Net financials
0
0
Profit before tax
−547
−51
Tax
−0
−0
Net profit
−547
−51
Balance sheet
NOK thousands
Item
2023
2024
Total assets
288
237
Equity
−522
−573
Long-term debt
0
0
Short-term debt
810
810
Total debt
810
810
Financial ratios
5-year trend
EBITDA-margin
-5114600.0%
This company
15.8%
Market median
-32370986% vs market
2023
2024
Soliditetsgrad
-242.2%
This company
38.2%
Market median
-734% vs market
2023
2024
Egenkapitalforrentning
-5114600.0%
This company
18.4%
Market median
-27796839% vs market
2023
2024
Nettoresultatgrad
-5114600.0%
This company
8.1%
Market median
-63143310% vs market
2023
2024
Aktivomsætning
0.00×
This company
1.12×
Market median
-100% vs market
2023
2024
Gæld/egenkapital
1.41×
This company
0.62×
Market median
-127% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-03-10 – 2023-12-31
View
PDF
More on LYNX PHARMA AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
